Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis


Por: Davison, BA, Abbate, A, Cotter, G, Pascual-Figal, D, Van Tassell, B, Villota, JN, Atabaeva, L, Freund, Y, Aimo, A, Biegus, J, Golino, M, Del Buono, MG, Chioncel, O, Cohen-Solal, A, Edwards, C, Fernández-Villa, N, Filippatos, G, González-Juanatey, JR, Hayrapetyan, H, Ibáñez, B, Iborra, PL, Moroni, F, ter Maaten, JM, Markley, R, González-Martín, J, Martínez-Sellés, M, Drambyan, M, Metra, M, Mirabet, S, Mshetsyan, A, Novosadova, M, Pagnesi, M, Ponikowski, P, Riquelme-Pérez, A, Sadoune, M, Sánchez, MA, Simon, T, Taibo-Urquía, M, Takagi, K, Villar, S, Liu, C, Voors, AA, Mebazaa, A, Mann, DL and Bayés-Genís, A

Publicada: 1 may 2025 Ahead of Print: 1 feb 2025
Resumen:
We examined current evidence regarding the effects of anti-inflammatory therapies in patients with acute heart failure (AHF) on the risk of cardiovascular outcomes, inflammatory markers, natriuretic peptides, and renal function. Despite growing evidence that inflammation plays a pivotal role in both the development and progression of heart failure, including AHF, only a few trials have been conducted to date in patients with AHF. A systematic literature search of PubMed, Medline, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov was conducted in November 2024 to identify randomized controlled trials (RCTs) evaluating anti-inflammatory therapies in adult patients with AHF. Meta-analyses were conducted to estimate effects on clinical outcomes (death, HF readmission, or worsening HF) and inflammatory and other markers. Five RCTs were identified that enrolled a total of 289 patients to an anti-inflammatory intervention and 273 to a control. Prednisone was examined in two RCTs, anakinra in two, and colchicine in one. Three of the five trials required elevated C-reactive protein (CRP) level for entry. Anti-inflammatory therapy was associated with a reduced risk of the composite outcome (hazard ratio 0.55 [95% CI 0.35-0.86]) and an overall 54% greater reduction in CRP to end of therapy (ratio of geometric mean ratios 0.46 [95% CI 0.29-0.73]), which varied across studies. NT-proBNP and creatinine were not significantly affected. The analysis is limited by the small number of studies but suggests that anti-inflammatory therapy reduces inflammation and may reduce the risk of adverse clinical outcomes in patients with AHF.

Filiaciones:
Davison, BA:
 Univ Paris Cite, INSERM UMR-S 942 MASCOT, Paris, France

 Heart Initiat, Durham, NC 27703 USA

 Momentum Res Inc, 1426 E NC Highway 54, Durham, NC 27713 USA

Abbate, A:
 Univ Virginia, Berne Cardiovasc Res Ctr, Charlottesville, VA USA

Cotter, G:
 Univ Paris Cite, INSERM UMR-S 942 MASCOT, Paris, France

 Heart Initiat, Durham, NC 27703 USA

 Momentum Res Inc, 1426 E NC Highway 54, Durham, NC 27713 USA

Pascual-Figal, D:
 Univ Murcia, Hosp Clin Univ Virgen Arrixaca, Murcia, Spain

 Ctr Nacl Invest Cardiovasc, Madrid, Spain

 CIBER Cardiovasc, Madrid, Spain

Van Tassell, B:
 Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA

Villota, JN:
 CIBER Cardiovasc, Madrid, Spain

 Hosp Clin Univ Valencia, Valencia, Spain

Atabaeva, L:
 Momentum Res Inc, 1426 E NC Highway 54, Durham, NC 27713 USA

Freund, Y:
 Sorbonne Univ, IMProving Emergency Care FHU, Paris, France

 Hop La Pitie Salpetriere, Assistance Publ Hop Paris AP HP, Emergency Dept, Paris, France

 Hop La Pitie Salpetriere, Assistance Publ Hop Paris AP HP, Serv Mobile Urgence & Reanimat SMUR, Paris, France

Aimo, A:
 Fdn Toscana Gabriele Monasterio, Pisa, Italy

Biegus, J:
 Wroclaw Med Univ, Inst Heart Dis, Wroclaw, Poland

Golino, M:
 Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA

Del Buono, MG:
 Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA

Chioncel, O:
 Univ Med & Pharm Carol Davila, Emergency Inst Cardiovasc Dis Prof CCIliescu, Bucharest, Romania

Cohen-Solal, A:
 Univ Paris Cite, INSERM UMR-S 942 MASCOT, Paris, France

 Lariboisiere Hosp, APHP Nord, Dept Cardiol, Paris, France

Edwards, C:
 Momentum Res Inc, 1426 E NC Highway 54, Durham, NC 27713 USA

Fernández-Villa, N:
 Univ Murcia, Hosp Clin Univ Virgen Arrixaca, Murcia, Spain

Filippatos, G:
 Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Sch Med, Athens, Greece

González-Juanatey, JR:
 CIBER Cardiovasc, Madrid, Spain

 Hosp Clin Univ Santiago, Santiago De Compostela, Spain

Hayrapetyan, H:
 Erebouni Med Ctr, Titogradyan Str, Yerevan 0087, Armenia

Ibáñez, B:
 Ctr Nacl Invest Cardiovasc, Madrid, Spain

 CIBER Cardiovasc, Madrid, Spain

 Hosp Fdn Jimenez Diaz, Madrid, Spain

Iborra, PL:
 Hosp Univ Ramon y Cajal, Madrid, Spain

Moroni, F:
 Univ Virginia, Berne Cardiovasc Res Ctr, Charlottesville, VA USA

Markley, R:
 Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Richmond, VA USA

González-Martín, J:
 CIBER Cardiovasc, Madrid, Spain

 Hosp Univ 12 Octubre, Madrid, Spain

Martínez-Sellés, M:
 Hosp Univ Gregorio Maranon, Madrid, Spain

Drambyan, M:
 Armenia Med Ctr, Yerevan, Armenia

Metra, M:
 Univ Brescia, ASST Spedali Civili Radiol Sci & Publ Hlth, Cardiol, Brescia, Italy

 Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlth, Brescia, Italy

Mirabet, S:
 CIBER Cardiovasc, Madrid, Spain

 Hosp St Creu i St Pau, Barcelona, Spain

Mshetsyan, A:
 Mikaelyan Inst Surg CJSC, Yerevan, Armenia

Novosadova, M:
 Momentum Res Inc, 1426 E NC Highway 54, Durham, NC 27713 USA

Pagnesi, M:
 Univ Brescia, ASST Spedali Civili Radiol Sci & Publ Hlth, Cardiol, Brescia, Italy

 Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlth, Brescia, Italy

Ponikowski, P:
 Wroclaw Med Univ, Inst Heart Dis, Wroclaw, Poland

Riquelme-Pérez, A:
 Univ Murcia, Hosp Clin Univ Virgen Arrixaca, Murcia, Spain

Sadoune, M:
 Univ Paris Cite, INSERM UMR-S 942 MASCOT, Paris, France

Sánchez, MA:
 Hosp Univ Reina Sofia, Cordoba, Spain

Simon, T:
 Sorbonne Univ, IMProving Emergency Care FHU, Paris, France

 St Antoine Hosp, Dept Clin Pharmacol & Clin Res Platform Paris East, URCEST CRC CRB, APHP, Paris, France

Taibo-Urquía, M:
 CIBER Cardiovasc, Madrid, Spain

 Hosp Fdn Jimenez Diaz, Madrid, Spain

Takagi, K:
 Momentum Res Inc, 1426 E NC Highway 54, Durham, NC 27713 USA

Villar, S:
 CIBER Cardiovasc, Madrid, Spain

 Hosp Clin Univ Valencia, Valencia, Spain

Liu, C:
 Hebei Med Univ, Hosp Hebei Med Univ 1, Shijiazhuang, Hebei, Peoples R China

Mebazaa, A:
 Univ Paris Cite, INSERM UMR-S 942 MASCOT, Paris, France

Mann, DL:
 Washington Univ, Sch Med, Cardiovasc Div, Dept Med, St Louis, MO 63110 USA

:
 CIBER Cardiovasc, Madrid, Spain

 Hosp Univ Germans Trial i Pujol, Badalona, Barcelona, Spain
ISSN: 15737322





Heart Failure Reviews
Editorial
Kluwer Academic Publishers, VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS, Países Bajos
Tipo de documento: Review
Volumen: 30 Número: 3
Páginas: 575-587
WOS Id: 001418890400001
ID de PubMed: 39939545
imagen Green Submitted

MÉTRICAS